Results 241 to 250 of about 191,466 (342)

Poly(ADP-ribosyl)ation basally activated by DNA strand breaks reflects glutamate–nitric oxide neurotransmission

, 2000
Andrew A. Pieper, Seth Blackshaw, Emily E. Clements, Daniel J. Brat, David K. Krug, Alison J. White, Patricia Pinto-Garcia, Antonella Favit, Jill R. Conover, Solomon H. Snyder, Ajay Verma   +10 more
openalex   +1 more source

Is there a role for cannabidiol in obesity, metabolic syndrome and binge eating?

British Journal of Pharmacology, EarlyView.
Cannabidiol (CBD) is one of the most abundant phytocannabinoids isolated from the Cannabis sativa plant. CBD is a lipophilic, non‐intoxicating substance that differently from Δ9‐tetrahydrocannabinol (Δ9‐THC) does not present the typical profile of a drug of abuse.
Luca Botticelli, Emanuela Micioni Di Bonaventura, Giacomo Einaudi, Gustavo Provensi, Alessia Costa, Claudio D'Addario, Carlo Cifani, Maria Vittoria Micioni Di Bonaventura   +7 more
wiley   +1 more source

Positioning berries in nutritional psychiatry: potential for prevention and co-therapy in mental health. [PDF]

Front Behav Neurosci
Fernández-Demeneghi R, Domínguez-Pantoja M, Martínez-Moreno AG, Vargas-Moreno I, Ramirez-Rodriguez R.   +4 more
europepmc   +1 more source

Role of Rab GDP dissociation inhibitor α in regulating plasticity of hippocampal neurotransmission

, 2000
Hiroyoshi Ishizaki, Jun Miyoshi, Haruyuki Kamiya, Atsushi Togawa, Miki Tanaka, Takuya Sasaki, Katsuaki Endo, Akira Mizoguchi, Seiji Ozawa, Yoshimi Takai   +9 more
openalex   +1 more source

Modeling cerebral palsy in animals

Developmental Medicine &Child Neurology, EarlyView.
Abstract Advancements in the treatment of cerebral palsy depend on animal research. Yet, most animal models have not been fully evaluated for spasticity and dystonia using clinically relevant measures of altered tone or movement patterns, which form the basis for diagnosing people with the condition.
Katharina A. Quinlan, Emily J. Reedich, Elvia Mena Avila, Brendan C. Moline, Landon T. Genry, Megan R. Detloff, Benjamin R. Katholi, Deborah Gaebler‐Spira, Bhooma R. Aravamuthan   +8 more
wiley   +1 more source

Glutamate-Mediated Neural Alterations in Lead Exposure: Mechanisms, Pathways, and Phenotypes. [PDF]

Toxics
Tamagno WA, Freeman JL.
europepmc   +1 more source

Three‐year outcomes of repeated botulinum neurotoxin A injections to the lower extremities in young children with spastic cerebral palsy in GMFCS levels I to III

Developmental Medicine &Child Neurology, EarlyView.
In this study, we followed a group of children 2 to 6 years old with spastic cerebral palsy functioning in GMFCS levels I–III, over 3 years. Sixty‐five received BoNT‐A and 59 did not. Repeated BoNT‐A injections over 3 years were not associated with improvements in gross motor function or passive ankle dorsiflexion. Daily step counts, favouring the BoNT‐
Darcy Fehlings, Emma Bohn, Lauren Switzer, Charles H. Goldsmith, Unni Narayanan, Peter L. Rosenbaum, F. Virginia Wright, Gary Foster, CP‐BoNT‐A Study Group, Timothy Carey, Mark Mason, Ronit Mesterman   +11 more
wiley   +1 more source

Editorial to the Special Issue "Glycine-(and D-Serine)-Related Neurotransmission: Promising Therapeutic Targets with Still Unsolved Problems". [PDF]

Biomedicines
Raiteri L.
europepmc   +1 more source

Psychiatric effects of GLP‐1 receptor agonists: A systematic review of emerging evidence

Diabetes, Obesity and Metabolism, EarlyView.
Abstract This systematic review examines the current literature on glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs)‐associated psychiatric manifestations, including depression, suicidality, eating disorders, substance use disorders (SUD) and schizophrenia spectrum disorders.
Brianna Sa, Anthony Maristany, Ashwin Subramaniam, Ryan Guillen, Brooke Buonocore, Audrey Smith, Sean E. Oldak, Vanessa Padilla   +7 more
wiley   +1 more source

Decomposing SV2A Function and Dysfunction one Neuron at a Time. [PDF]

Epilepsy Curr
Safari M, Weston MC.
europepmc   +1 more source